Clinical Trial Update: Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent [NA]

View source ↗

Summary

A non-inferiority clinical trial evaluating the Evolution Coronary Stent for safety and performance in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Evolution Coronary Stent

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | NA | Status: COMPLETED